Overview


According to FutureWise analysis the market for Animal Model in 2023 is US$ 1.82 billion, and is expected to reach US$ 3.08 billion by 2031 at a CAGR of 6.80%.

An animal model is a non-human species employed in biomedical research as it can replicate facets of human biological processes or diseases observed in species other than humans. Animal models such as mice, rats, monkeys, zebrafish, and others, exhibit substantial similarity to humans in terms of their anatomy, physiology, or responses to pathogens. The insights gained from studies conducted on animal models allow researchers to extend their understanding of human physiology and ailments. Additionally, these models facilitate the execution of experiments that might need to be more practical or ethically restricted when involving human subjects.

Animal models are mainly used to determine if a drug is safe. A researcher can also test different doses of a product and its nature, chemistry, and effects in the body, such as how much drug is absorbed into the blood, how long it lasts, and how it is broken down chemically. Animal models also allow for testing of the toxicity of a product and its breakdown components (metabolites). Before beginning a clinical trial, animal models help determine a dose and schedule for human subjects. When submitting an Investigational New Drug application to FDA – the regulatory step to get approval to conduct human studies – researchers must conduct toxicology tests (to study adverse effects) in two animal models.

FutureWise Market Research has published a report that provides an insightful analysis animal model market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, animal model market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Charles River
  • Envigo
  • genOway
  • Harbour BioMed
  • Janvier Labs
  • PharmaLegacy
  • Taconic Biosciences Inc.
  • The Jackson Laboratory
  • TRANS GENIC INC, Ltd
  • Mylan NV
  • Horizon Discovery Group plc
  • Eurofins Scientific SE
  • Crown Bioscience, Inc.
  • Transposagen Biopharmaceuticals, Inc.
  • Harlan Laboratories

(Note: The list of the major players will be updated with the latest market scenario and trends)
 

Recent Developments in Animal Model Market:

  • In January 2023- Charles River Laboratories announced that it had expanded its triple-immunodeficient mouse model portfolio by introducing two new NCG mouse strains best suited for oncology, immunology, and infectious diseases studies.
     
  • In September 2022- a new framework was introduced to the strategic alliance in the CRISPR/Cas9 domain by Sigma-Aldrich Co. LLC and genOway.

The widespread adoption of CRISPR technology has emerged as a transformative and potent driver propelling the animal model market over the forecast period. This revolutionary gene-editing tool has revolutionized the creation of precise and sophisticated animal models, enabling researchers to develop highly accurate disease models, investigate gene function, and unravel intricate molecular mechanisms underlying various physiological and pathological processes. For instance, according to a 2022 report from the National Library of Medicine, CRISPR's application in cancer research exemplifies its role in innovatively modeling the disease. This involves generating pre-clinical cancer models through CRISPR-induced mutations that mimic human malignancies, enabling a detailed exploration of cancer mechanisms and potential therapeutic approaches. Moreover, the Growing incidence of complex diseases and the need for thorough pre-clinical drug screening before progressing to clinical trials have positioned animal models as indispensable tools in biomedical research. This essential role stems from their ability to closely mimic human physiological and pathological conditions, enabling the evaluation of potential drug candidates for safety and efficacy. As pharmaceutical and biotechnology industries increasingly prioritize precision medicine and targeted therapies, the demand for specialized and genetically engineered animal models is projected to rise. Furthermore, the ethical concerns and moral considerations about animal welfare linked to their utilization in research are likely to hinder market growth. These concerns underscore the need for responsible and humane treatment of animals, creating a challenge in striking a balance between scientific advancements and ethical responsibilities. Moreover, growing opportunities from partnerships between pharmaceutical companies, academic institutions, and contract research organizations (CROs) as they join forces to create and harness animal models. These collaborations offer a chance for shared expertise, resources, and knowledge, leading to an enhanced understanding of diseases and potential treatments. Such teamwork enables the efficient development of advanced and reliable animal models that more accurately mimic human conditions, accelerating drug discovery and pre-clinical testing.

By Animal Type

  • Mice
  • Rats
  • Fish
  • Birds
  • Cattles
  • Pigs
  • Amphibians
  • Guinea Pigs
  • Dogs
  • Cats
  • Rabbits
  • Monkeys
  • Sheep
  • Hamsters
  • Others

By Technology

  • CRISPR
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Others

By Application

  • Research & Development
    • Infectious Disease
    • Immunological Disease
    • Cancer
    • Cardiovascular Disease
    • Diabetes
    • Genetic Disease
    • Neurological Disease
    • Obesity
    • NAFLD/NASH
    • Renal Disease
    • Diabetic Eye Disease
    • Fibrosis
    • Microbiome
    • Others
  • Production & Quality Control
  • Academics
  • Preclinical Applications
  • Other

By Use

  • Human
  • Veterinary

By End-Use

  • Companies
    • Pharmaceutical
    • Biotechnology
    • Cosmetics
    • Others
  • Organizations
    • Government
    • Non-government
  • Academic & Research Institutes
  • Contract Research Organizations

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is attributed to the high increase in research and development activities by pharmaceutical and biotechnology companies and the strong presence of key market players to provide animal models to meet the demand. Additionally, the region is marked by major players operating in the mice model market, growing biomedical research in the United States, and rising preclinical activities by clinical research organizations (CROs) and pharmaceutical companies in the region. Therefore, the above-mentioned aspects are further expected to propel the growth of the animal model market during the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Animal Model Market By Animal Type, By Technology, By Application, By Use, By End-Use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Animal Model Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal Model Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Animal Model Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Animal Model Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Mice
        2. Rats
        3. Fish
        4. Birds
        5. Cattles
        6. Pigs
        7. Amphibians
        8. Guinea Pigs
        9. Dogs
        10. Cats
        11. Rabbits
        12. Monkeys
        13. Sheep
        14. Hamsters
        15. Others

  • 8.   Global Animal Model Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. CRISPR
        2. Microinjection
        3. Embryonic Stem Cell Injection
        4. Nuclear Transfer
        5. Others

  • 9.   Global Animal Model Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Research & Development
         1.1. Infectious Disease
         1.2. Immunological Disease
         1.3. Cancer
         1.4. Cardiovascular Disease
         1.5. Diabetes
         1.6. Genetic Disease
         1.7. Neurological Disease
         1.8. Obesity
         1.9. NAFLD/NASH
         1.10.Renal Disease
         1.11.Diabetic Eye Disease
         1.12.Fibrosis
         1.13.Microbiome
         1.14.Others
        2. Production & Quality Control
        3. Academics
        4. Preclinical Applications
        5. Others

  • 10.   Global Animal Model Market, By Use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Human
        2. Veterinary

  • 11.   Global Animal Model Market, By End-Use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Companies
         1.1. Pharmaceutical
         1.2. Biotechnology
         1.3. Cosmetics
         1.4. Others
        2. Organizations
         2.1. Government
         2.2. Non-government
        3. Academic & Research Institutes
        4. Contract Research Organizations

  • 12.   North America Animal Model Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Animal Model Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Animal Model Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Animal Model Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Charles River
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Envigo
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. genOway
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Harbour BioMed
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Janvier Labs
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. PharmaLegacy
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
         7. Taconic Biosciences Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
         8. The Jackson Laboratory.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. TRANS GENIC INC, Ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Mylan NV
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Horizon Discovery Group plc
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Eurofins Scientific SE
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
         13.Crown Bioscience, Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
         14.Transposagen Biopharmaceuticals, Inc.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Harlan Laboratories
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client

Related Market

Humanized Liver Mice Model

Read More

Rat Model Market

Read More

Mice Model Market

Read More
Partner

Our Clients